Table 2.
Characteristics | Control (n = 50) | Patients with hepatitis C without HCC (n = 50) | Patients with HCV-related HCC(n = 50) | Test of sig. | p-value |
---|---|---|---|---|---|
ALT (U/l), mean ±SD | 20.70 ±4.94 | 46.0 ±17.87 | 69.54 ±21.75 | F = 109.535* | < 0.001* |
AST (U/l), mean ±SD | 24.32 ±7.74 | 51.83 ±22.47 | 83.04 ±22.56 | H = 107.496* | < 0.001* |
Albumin (gm/dl), mean ±SD | 4.74 ±0.41 | 3.88 ±0.85 | 2.20 ±0.58 | F = 201.361* | < 0.001* |
D.Bil. (mg/dl), mean ±SD | 0.31 ±0.15 | 0.45 ±0.18 | 2.50 ±1.18 | H = 107.789* | < 0.001* |
Sig. bet. grps | p1 < 0.05*, p2 < 0.001*, p3 < 0.001* |
ALT – alanine aminotransferase, AST– aspartate aminotransferase, D.Bil – direct bilirubin, F – ANOVA test, H – Kruskal-Wallis test, pairwise comparison bet. each 2 groups was done using Post Hoc Test, p – p-value for comparing between the studied groups, p1 – p-value for comparing between control and HCV, p2 – p-value for comparing between the control and HCC, p3 – p-value for comparing between the HCV and HCC, *statistically significant at p ≤ 0.05